E115: Benralizumab for EGPA - the MANDARA Study - The Evidence Based Rheumatology Podcast

All Episodes

E115: Benralizumab for EGPA - the MANDARA Study

October 28, 2024 • 9 mins

Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.

MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

.css-15opob5{left:0;position:absolute;top:0.8rem;} All Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;}E115: Benralizumab for EGPA - the MANDARA Study

Popular Podcasts

.css-r6mb8g{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:1;overflow:hidden;}Stuff You Should Know

Dateline NBC

24/7 News: The Latest

All Episodes

E115: Benralizumab for EGPA - the MANDARA Study

Stuff You Should Know